Live Quote · NASDAQNTRBHealthcare· Biotechnology

Nutriband Inc.

$3.06 0.97%($-0.03)
TickerSpark Score
41/100
Weak
50
Valuation
30
Profitability
15
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NTRB research report →

52-Week Range2% of range
Low
$2.90
Current
$3.06
High
$9.83
Company Overviewnutriband.com

About the company

Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse.

CEO
Gareth Sheridan
IPO
2021
Employees
13
HQ
Orlando, FL, US

Price Chart

-71.46% · this period
$10.72$6.81$2.90Jul 02Dec 31Jul 02
Valuation
Market Cap
$37.20M
P/E
-1.17
P/S
20.64
P/B
6.21
EV/EBITDA
-4.24
Div Yield
0.00%
Profitability
Gross Margin
28.35%
Op Margin
-452.61%
Net Margin
-448.39%
ROE
-112.60%
ROIC
-131.11%
Growth & Income
Revenue
$2.04M · -4.83%
Net Income
$-8,229,632 · 21.50%
EPS
$-2.58 · -160.61%
Op Income
$-8,317,961
FCF YoY
-8.81%
Performance & Tape
52W High
$9.83
52W Low
$2.90
50D MA
$3.52
200D MA
$4.74
Beta
1.93
Avg Volume
10.74K

Get TickerSpark's AI analysis on NTRB

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jan 31, 25Sheridan Garethother0
Jan 29, 25Sheridan Garethother29,333
Mar 20, 24Sheridan Garethother97,500
Jan 23, 25Goodman Geraldother17,667
Mar 19, 24Goodman Geraldother75,000
Jun 5, 24Goodman Geraldother60,085
Mar 20, 24Goodman Geraldother75,000
Jun 6, 24Goodman Geraldother87,500
Mar 20, 24MELNIK SERGUEIother97,500
Mar 20, 24Sheridan Garethother75,000
Coverage · NTRB

Our NTRB coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on NTRB yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate NTRB report →
Internal Compare

Similar companies

Peers in the same neighborhood.